Home
Live Updates
Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology : comparemela.com
Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences Team, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology
/PRNewswire/ -- Grey Wolf Therapeutics ("Grey Wolf" or "the company"), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation...
Related Keywords
United States ,
London ,
City Of ,
United Kingdom ,
Australia ,
American ,
British ,
Catherine Armstrong ,
Peter Joyce ,
Tim Brons ,
Tracy Weightman ,
Oxford Science Enterprises ,
Instagram ,
Head Of Corporate Communications ,
American Society Of Clinical Oncology ,
Linkedin ,
London Stock Exchange ,
Life Sciences ,
Brings Total Seriesb Funds Raised ,
Support Broadening Scope ,
Ongoing Clinical Trial ,
First Clinical Data ,
Expand Rd Efforts ,
Develop Disease Modifying Therapies ,
Wolf Therapeutics ,
Pfizer Ventures ,
Andera Partners ,
Earlybird Venture Capital ,
British Patient ,
Grey Wolf ,
Clinical Oncology ,
Associate Director ,
Private Equity ,
Private Debt ,
Real Assets ,
Strategic Partners ,
comparemela.com © 2020. All Rights Reserved.